KAITLIN WOJCEHOWSKI: Open Payments
NPI 1992427652 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 33 payments from 10 companies in 2025. Trend: 2023 $931 · 2024 $663 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $187 |
| Edwards Lifesciences Corporation | 1 | $150 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $110 |
| Amgen Inc. | 3 | $44 |
| PFIZER INC. | 2 | $38 |
| Recor Medical Inc | 1 | $31 |
| Shionogi Inc | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: LEQVIO, PASCAL, LifeVest, REPATHA, VYNDAQEL, ENTRESTO, Paradise Ultrasound Renal Denervation System, Fetroja.
Industry payments across IN — which companies pay providers there.
